Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
Aim: This study aims to determine the incidence of all immune-mediated adverse events (IMAEs) with a focus on hypophysitis in patients with metastatic melanoma receiving immune checkpoint inhibitors (ICI). Methods: 51 patients with metastatic melanoma who received immune checkpoint inhibitors (ipili...
Saved in:
| Main Authors: | Khor Zhong Wei, Mark Baxter, Richard Casasola |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-03-01
|
| Series: | Melanoma Management |
| Subjects: | |
| Online Access: | https://www.futuremedicine.com/doi/10.2217/mmt-2018-0009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant immunotherapy with ipilimumab/nivolumab induces a complete response of a primary malignant melanoma in an 89 years old patient
by: Pascal Spahn, et al.
Published: (2024-12-01) -
Analysis of the clinical characteristics of immune checkpoint inhibitor-related hypophysitis
by: Zhixiao WANG, et al.
Published: (2025-08-01) -
Combatting mucosal melanoma: recent advances and future perspectives
by: Helen Tyrrell, et al.
Published: (2018-09-01) -
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data
by: Andrea Ossato, et al.
Published: (2023-02-01) -
Two cases of Stevens-Johnson syndrome presenting severe ocular complications associated with immune checkpoint inhibitor
by: Yukiko Nakahara-Omori, et al.
Published: (2025-07-01)